Chemoinformaics analysis of 2-Methyl-2-cyclopenten-1-one
Molecular Weight | 96.129 | nRot | 0 |
Heavy Atom Molecular Weight | 88.065 | nRig | 6 |
Exact Molecular Weight | 96.0575 | nRing | 1 |
Solubility: LogS | -0.851 | nHRing | 0 |
Solubility: LogP | 1.092 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 16.1563 |
nHD | 0 | BPOL | 8.89366 |
QED | 0.444 |
Synth | 2.836 |
Natural Product Likeliness | 2.211 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.349 |
MDCK | 0.0000307 |
BBB | 0.997 |
PPB | 0.446402 |
VDSS | 0.784 |
FU | 0.680228 |
CYP1A2-inh | 0.433 |
CYP1A2-sub | 0.724 |
CYP2c19-inh | 0.136 |
CYP2c19-sub | 0.822 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.611 |
CYP2d6-inh | 0.025 |
CYP2d6-sub | 0.68 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.238 |
CL | 9.27 |
T12 | 0.819 |
hERG | 0.011 |
Ames | 0.013 |
ROA | 0.435 |
SkinSen | 0.948 |
Carcinogencity | 0.794 |
EI | 0.991 |
Respiratory | 0.374 |
NR-Aromatase | 0.035 |
Antiviral | No |
Prediction | 0.948861 |